Hélène Pasquer

4PUBLICATIONS

47CO-AUTHORS

Molecular targetsPredictive and prognostic markersGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 08, 2026

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Oct 30, 2024

Current myeloproliferative neoplasm scoring systems for clinical practice.

Hélène Pasquer, Jean-Jacques Kiladjian, Lina Benajiba

|Apr 19, 2024

INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment.

Manuela Bratti, Elisa Stubbs, Sergii Kolodych

|Mar 13, 2021

Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.

Hélène Pasquer, Karim Belhadj, Jehan Dupuis

Pageof 1

Frequent Collaborators

Lina Benajiba

Lois M Kelly

Alexandre Puissant

Karim Belhadj

Manuela Bratti

Elisa Stubbs

Sergii Kolodych

Herve Souchet

Johanna Merlin

Michelle Marchal

Frequent Collaborators

Lina Benajiba

Lois M Kelly

Alexandre Puissant

Karim Belhadj